Vir Biotechnology financial statements

버 바이오테크놀로지NASDAQ:VIR · Nasdaq · Healthcare · sector #17
$11.60-1.53%
2026-10-06 close

Vir Biotechnology's published financial data is dated 2026-10-04. 2024 revenue was $74M. 2024 operating profit was −$587M.

Reported results

Vir Biotechnology notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q